Circulating irisin, omentin-1, and lipoprotein subparticles in adults at higher cardiovascular risk

Metabolism: Clinical and Experimental

Volumn 63, Issue 10, 2014, Pages 1265-1271

  Panagiotou, Grigorios ^a   Mu, Lin ^a   Na, Brian ^a   Mukamal, Kenneth J ^a   Mantzoros, Christos S ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Atherosclerosis; Fibronectin type III domain containing 5; Longitudinal biomarker; Metabolic syndrome; Myokine

Indexed keywords

CYTOKINE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IRISIN; LIPOPROTEIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; OMENTIN 1; RESISTIN; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; BIOLOGICAL MARKER; FIBRONECTIN; FIBRONECTIN TYPE III DOMAIN CONTAINING 5; FNDC5 PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; ITLN1 PROTEIN, HUMAN; LECTIN; MYOKINE;

ADULT; AGE; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; DIABETES MELLITUS; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MALE; METABOLIC PARAMETERS; RACE; RANDOMIZED CONTROLLED TRIAL; SEX; SMOKING; ATHEROSCLEROSIS; BLOOD; CARDIOVASCULAR DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; LONGITUDINAL BIOMARKER; METABOLIC SYNDROME X; MIDDLE AGED; RISK FACTOR;

ATHEROSCLEROSIS; FIBRONECTIN TYPE III DOMAIN CONTAINING 5; LONGITUDINAL BIOMARKER; METABOLIC SYNDROME; MYOKINE;

BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; CYTOKINES; FEMALE; FIBRONECTINS; GPI-LINKED PROTEINS; HUMANS; LECTINS; LIPOPROTEINS; MALE; MIDDLE AGED; RESISTIN; RISK FACTORS;

EID: 84908225577     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.06.001     Document Type: Article

References (55)

1. H.B. Hubert, M. Feinleib, P.M. McNamara, and W.P. Castelli Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study Circulation 67 1983 968 977
2. J. Van de Voorde, B. Pauwels, C. Boydens, and K. Decaluwe Adipocytokines in relation to cardiovascular disease Metab Clin Exp 62 2013 1513 1521
3. N.P. Kadoglou, N. Sailer, A. Moumtzouoglou, A. Kapelouzou, H. Tsanikidis, and I. Vitta Visfatin (nampt) and ghrelin as novel markers of carotid atherosclerosis in patients with type 2 diabetes Exp Clin Endocrinol Diabetes 118 2010 75 80
4. T.B. Dahl, A. Yndestad, M. Skjelland, E. Oie, A. Dahl, and A. Michelsen Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis: possible role in inflammation and plaque destabilization Circulation 115 2007 972 980
5. C. Chen, J. Jiang, J.M. Lu, H. Chai, X. Wang, and P.H. Lin Resistin decreases expression of endothelial nitric oxide synthase through oxidative stress in human coronary artery endothelial cells Am J Physiol Heart Circ Physiol 299 2010 H193 H201
6. I. Shai, M.B. Schulze, J.E. Manson, K.M. Rexrode, M.J. Stampfer, and C. Mantzoros A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes Diabetes Care 28 2005 1376 1382
7. R.Z. Yang, M.J. Lee, H. Hu, J. Pray, H.B. Wu, and B.C. Hansen Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am J Physiol Endocrinol Metab 290 2006 E1253 E1261
8. T. Komiya, Y. Tanigawa, and S. Hirohashi Cloning of the novel gene intelectin, which is expressed in intestinal paneth cells in mice Biochem Biophys Res Commun 251 1998 759 762
9. C.M. de Souza Batista, R.Z. Yang, M.J. Lee, N.M. Glynn, D.Z. Yu, and J. Pray Omentin plasma levels and gene expression are decreased in obesity Diabetes 56 2007 1655 1661
10. H.Y. Pan, L. Guo, and Q. Li Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes Diabetes Res Clin Pract 88 2010 29 33
11. P. Yan, D. Liu, M. Long, Y. Ren, J. Pang, and R. Li Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus Exp Clin Endocrinol Diabetes 119 2011 257 263
12. K. Kazama, T. Usui, M. Okada, Y. Hara, and H. Yamawaki Omentin plays an anti-inflammatory role through inhibition of TNF-alpha-induced superoxide production in vascular smooth muscle cells Eur J Pharmacol 686 2012 116 123
13. H. Yamawaki, N. Tsubaki, M. Mukohda, M. Okada, and Y. Hara Omentin, a novel adipokine, induces vasodilation in rat isolated blood vessels Biochem Biophys Res Commun 393 2010 668 672
14. S. Greulich, W.J. Chen, B. Maxhera, L.J. Rijzewijk, R.W. van der Meer, and J.T. Jonker Cardioprotective properties of omentin-1 in type 2 diabetes: evidence from clinical and in vitro studies PLoS One 8 2013 e59697 10.1371/journal.pone.0059697
15. R. Shibata, N. Ouchi, R. Kikuchi, R. Takahashi, K. Takeshita, and Y. Kataoka Circulating omentin is associated with coronary artery disease in men Atherosclerosis 219 2011 811 814
16. J.M. Moreno-Navarrete, V. Catalan, F. Ortega, J. Gomez-Ambrosi, W. Ricart, and G. Fruhbeck Circulating omentin concentration increases after weight loss Nutr Metab 7 2010 27
17. A. Prats-Puig, J. Bassols, E. Bargallo, M. Mas-Parareda, R. Ribot, and P. Soriano-Rodriguez Toward an early marker of metabolic dysfunction: omentin-1 in prepubertal children Obesity 19 2011 1905 1907
18. B.K. Pedersen, and M.A. Febbraio Muscles, exercise and obesity: skeletal muscle as a secretory organ Nat Rev Endocrinol 8 2012 457 465
19. B.K. Pedersen, A. Steensberg, C. Fischer, C. Keller, P. Keller, and P. Plomgaard Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil 24 2003 113 119
20. P. Bostrom, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, and J.C. Lo A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 2012 463 468
21. J.Y. Huh, G. Panagiotou, V. Mougios, M. Brinkoetter, M.T. Vamvini, and B.E. Schneider FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise Metab Clin Exp 61 2012 1725 1738
22. J.M. Moreno-Navarrete, F. Ortega, M. Serrano, E. Guerra, G. Pardo, and F. Tinahones Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance J Clin Endocrinol Metab 98 2013 E769 E778
23. A. Stengel, T. Hofmann, M. Goebel-Stengel, U. Elbelt, P. Kobelt, and B.F. Klapp Circulating levels of irisin in patients with anorexia nervosa and different stages of obesity - correlation with body mass index Peptides 39 2013 125 130
24. K.H. Park, L. Zaichenko, P. Peter, C.R. Davis, J.A. Crowell, and C.S. Mantzoros Diet quality is associated with circulating C-reactive protein but not irisin levels in humans Metab Clin Exp 63 2014 233 241
25. M.T. Vamvini, K.N. Aronis, G. Panagiotou, J.Y. Huh, J.P. Chamberland, and M.T. Brinkoetter Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans Eur J Endocrinol 169 2013 829 834
26. A.B. Crujeiras, M.A. Zulet, P. Lopez-Legarrea, R. de la Iglesia, M. Pardo, and M.C. Carreira Association between circulating irisin levels and the promotion of insulin resistance during the weight maintenance period after a dietary weight-lowering program in obese patients Metabolism 63 2014 520 531 10.1016/j.metabol.2013.12.007
27. Y.K. Choi, M.K. Kim, K.H. Bae, H.A. Seo, J.Y. Jeong, and W.K. Lee Serum irisin levels in new-onset type 2 diabetes Diabetes Res Clin Pract 100 2013 96 101
28. J.J. Liu, M.D. Wong, W.C. Toy, C.S. Tan, S. Liu, and X.W. Ng Lower circulating irisin is associated with type 2 diabetes mellitus J Diabetes Complicat 27 2013 365 369
29. K.H. Park, L. Zaichenko, M. Brinkoetter, B. Thakkar, A. Sahin-Efe, and K.E. Joung Circulating irisin in relation to insulin resistance and the metabolic syndrome J Clin Endocrinol Metab 98 2013 4899 4907
30. S. Mora, J.D. Otvos, N. Rifai, R.S. Rosenson, J.E. Buring, and P.M. Ridker Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women Circulation 119 2009 931 939
31. R.M. Krauss Lipoprotein subfractions and cardiovascular disease risk Curr Opin Lipidol 21 2010 305 311
32. D.J. Buysse, C.F. Reynolds III, T.H. Monk, S.R. Berman, and D.J. Kupfer The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research Psychiatry Res 28 1989 193 213
33. J.S. Carpenter, and M.A. Andrykowski Psychometric evaluation of the Pittsburgh Sleep Quality Index J Psychosom Res 45 1998 5 13
34. L. Dipietro, C.J. Caspersen, A.M. Ostfeld, and E.R. Nadel A survey for assessing physical activity among older adults Med Sci Sports Exerc 25 1993 628 642
35. E.J. Jeyarajah, W.C. Cromwell, and J.D. Otvos Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy Clin Lab Med 26 2006 847 870
36. P.A. Harris, R. Taylor, R. Thielke, J. Payne, N. Gonzalez, and J.G. Conde Research electronic data capture (REDCap) - a metadata-driven methodology and workflow process for providing translational research informatics support J Biomed Inform 42 2009 377 381
37. J.Y. Huh, V. Mougios, A. Skraparlis, A. Kabasakalis, and C.S. Mantzoros Irisin in response to acute and chronic whole-body vibration exercise in humans Metabolism 63 2014 918 921 10.1016/j.metabol.2014.04.001
38. P.A. Bostrom, and J.M. Fernandez-Real Metabolism: irisin, the metabolic syndrome and follistatin in humans Nat Rev Endocrinol 10 2014 11 12
39. S.A. Polyzos, J. Kountouras, K. Shields, and C.S. Mantzoros Irisin: a renaissance in metabolism? Metab Clin Exp 62 2013 1037 1044
40. A. Roca-Rivada, C. Castelao, L.L. Senin, M.O. Landrove, J. Baltar, and A. Belen Crujeiras FNDC5/irisin is not only a myokine but also an adipokine PLoS One 8 2013 e60563 10.1371/journal.pone.0060563
41. H.P. Erickson Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte 2 2013 289 293
42. S. Raschke, M. Elsen, H. Gassenhuber, M. Sommerfeld, U. Schwahn, and B. Brockmann Evidence against a beneficial effect of irisin in humans PLoS One 8 2013 e73680 10.1371/journal.pone.0073680
43. P.A. Bostrom, J.M. Fernandez-Real, and C. Mantzoros Irisin in humans: recent advances and questions for future research Metab Clin Exp 63 2014 178 180
44. I. Gouni-Berthold, H.K. Berthold, J.Y. Huh, R. Berman, N. Spenrath, and W. Krone Effects of lipid-lowering drugs on irisin in human subjects in vivo and in human skeletal muscle cells ex vivo PLoS One 8 2013 e72858 10.1371/journal.pone.0072858
45. R. de la Iglesia, P. Lopez-Legarrea, A.B. Crujeiras, M. Pardo, F.F. Casanueva, and M.A. Zulet Plasma irisin depletion under energy restriction is associated with improvements in lipid profile in metabolic syndrome patients Clin Endocrinol 2013
46. M. Lehti, E. Donelan, W. Abplanalp, O. Al-Massadi, K.M. Habegger, and J. Weber High-density lipoprotein maintains skeletal muscle function by modulating cellular respiration in mice Circulation 128 2013 2364 2371
47. J.M. Moreno-Navarrete, F. Ortega, A. Castro, M. Sabater, W. Ricart, and J.M. Fernandez-Real Circulating omentin as a novel biomarker of endothelial dysfunction Obesity 19 2011 1552 1559
48. A.A. Bremer, and I. Jialal Adipose tissue dysfunction in nascent metabolic syndrome J Obes 8 2013 10.1155/2013/393192
49. I. Jialal, S. Devaraj, H. Kaur, B. Adams-Huet, and A.A. Bremer Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome J Clin Endocrinol Metab 98 2013 E514 E517
50. H.J. Yoo, S.Y. Hwang, H.C. Hong, H.Y. Choi, S.J. Yang, and K.W. Lee Implication of circulating omentin-1 level on the arterial stiffening in type 2 diabetes mellitus Endocrine 44 2013 680 687
51. R. Shibata, R. Takahashi, Y. Kataoka, K. Ohashi, N. Ikeda, and S. Kihara Association of a fat-derived plasma protein omentin with carotid artery intima-media thickness in apparently healthy men Hypertens Res 34 2011 1309 1312
52. H. Yamawaki, J. Kuramoto, S. Kameshima, T. Usui, M. Okada, and Y. Hara Omentin, a novel adipocytokine inhibits TNF-induced vascular inflammation in human endothelial cells Biochem Biophys Res Commun 408 2011 339 343
53. T. Auguet, Y. Quintero, D. Riesco, B. Morancho, X. Terra, and A. Crescenti New adipokines vaspin and omentin. Circulating levels and gene expression in adipose tissue from morbidly obese women BMC Med Genet 12 2011 60
54. S. Blüher, G. Panagiotou, D. Petroff, J. Markert, A. Wagner, and T. Klemm Effects of a 1-year exercise and lifestyle intervention on irisin, adipokines, and inflammatory markers in obese children Obesity 22 2014 1701 1708 10.1002/oby.20739
55. B. Yan, X. Shi, H. Zhang, L. Pan, Z. Ma, and S. Liu Association of serum irisin with metabolic syndrome in obese Chinese adults PLoS One 9 2014 e94235 10.1371/journal.pone.0094235